David Khayat
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
Comprehensive integrative profiling of upper tract urothelial carcinomas.
Journal: Genome biology
Published: May 31, 2020
Phase II randomised discontinuation trial of brivanib in patients with advanced solid tumours.
Journal: European journal of cancer (Oxford, England : 1990)
Published: May 28, 2019
6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial.
Journal: Lancet (London, England)
Published: January 20, 2019
Long-Term Survival in Gastroesophageal Junction Adenocarcinoma: Ramucirumab.
Journal: Case reports in gastroenterology
Published: May 21, 2018
Early onset breast cancer: differences in risk factors, tumor phenotype, and genotype between North African and South European women.
Journal: Breast cancer research and treatment
Published: July 27, 2017
Expression of long non-coding RNA MFI2-AS1 is a strong predictor of recurrence in sporadic localized clear-cell renal cell carcinoma.
Journal: Scientific reports
Published: April 24, 2017
NSD1 Inactivation and SETD2 Mutation Drive a Convergence toward Loss of Function of H3K36 Writers in Clear Cell Renal Cell Carcinomas.
Journal: Cancer research
Published: January 25, 2017
Prospective: How will renal, prostatic and urothelial tumours be treated in 10 years?
Journal: Nephrologie & therapeutique
Published: January 16, 2017
Therapeutic Strategies for Patients With Metastatic Renal Cell Carcinoma in Whom First-Line Vascular Endothelial Growth Factor Receptor-Directed Therapies Fail.
Journal: Journal of oncology practice
Published: May 13, 2016
Last Updated: 09/26/2026